skip to Main Content

Highmark Blue Cross Blue Shield March 2018 Medical Policy Updates

Highmark Blue Cross Blue Shield March 2018 Medical Policy Updates
Highmark Blue Cross Blue Shield

Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates »

March 2018 Medical Policy Updates:

  • Coverage for the Shingles Vaccine Shingrix Established
  • Coverage Criteria Revised for the Treatment of Gaucher Disease
  • Coverage Criteria Revised for Certolizumab (Cimzia)
  • Coverage Criteria Established for Infliximab-qbtx (Ixifi)
  • Coverage Criteria Revised for Tocilizumab (Actemra)
  • Criteria Revised for Golimumab (Simponi, Simponi Aria)
  • Coverage Criteria Revised for Ustekinumab (Stelara)
  • Criteria Revised for Agalsidase beta (Fabrazyme)
  • Coverage Criteria Revised for Abatacept (Orencia)
  • Coverage Criteria Revised for Cetuximab (Erbitux)
  • Coverage Criteria Revised for Treatment of Hereditary Angioedema (HAE)
  • Coverage Criteria Revised for Vedolizumab (Entyvio)
  • Coverage Criteria Revised for Obinutuzumab (Gazyva)
  • Coverage Position Established for GI Effects Comprehensive Stool Profile
  • Coverage Criteria Revised for Assisted Reproductive Technology
  • Revised Criteria for Transcranial Magnetic Stimulation (TMS)
  • Coverage Criteria Revised for Hyaluronan Injections for Osteoarthritis of the Knee
  • Policy Coverage Update Team Surgery
  • Policy Coverage Update Assistant Surgery Eligibility Criteria
  • Policy Coverage Update Co-Surgery
  • Coverage Guidelines Revised for Recombinant Platelet-Derived Growth Factors
  • Coverage Criteria Established for Tocilizumab (Actemra)
  • Coverage Criteria Established for Belimumab (Benlysta)
  • Coverage Criteria Revised for Cetuximab (Erbitux)
  • Coverage Criteria Revised for Obinutuzumab (Gazyva)
  • Coverage Criteria Established for Certolizumab (Cimzia)
  • New Policy Established for AlloSure Donor-Derived Cell-Free DNA Test
  • Policy Coverage Update Team Surgery
  • Policy Coverage Update Co-Surgery

 

Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top